Generare
PrivateLast Round
Series A
Apr 2, 2026
Total Funding Raised
$28.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Generare operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in April 2026.
Generare is a biotechnology company that has developed a data-driven discovery platform to identify novel bioactive molecules from microbes for applications in medicine and other industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Generare Comparables
Compare Generare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hexagon Bio | 82% | |
| Empress Therapeutics | 78% | |
| Biomia | 77% |
For institutional investors. Book with your work email.
Generare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 2, 2026 | ||||
| Seed | Oct 8, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Generare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Alven | Series A |
| SynBioVen | Seed |
| Daphni | Series A |
| Galion.exe | Series A, Seed |
| VIVES Partners | Series A, Seed |
| Better Angle | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 467% MoM, from 381 to 2.2K.
- Apr 2, 2026
$23M round completed.
For institutional investors. Book with your work email.
Generare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Generare's valuation, stock price, and market status.
Is Generare a public or private company?
Generare is a private company.
What is the current stock price of Generare?
Generare is a private company, so its shares have no public market price. Caplight tracks Generare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Generare worth (valuation)?
Valuation information for Generare is not publicly available.
Can I buy Generare stock?
Generare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Generare's last funding round?
Generare's most recent funding round was Series A on April 2, 2026.
Who are the main investors in Generare?
Key investors in Generare include Alven, Daphni, Galion.exe, VIVES Partners, Teampact Ventures.
Will Generare IPO soon?
No public IPO plans have been announced for Generare.
How can I track Generare secondary market activity?
Caplight tracks bids, offers, and trades in Generare's shares on secondary markets.